Ajooni Biotech [AJOONI] vs Nakoda Group of [NGIL] Detailed Stock Comparison

Ajooni Biotech Ltd.

NSE
Loading...

Nakoda Group of Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Ajooni Biotech Ltd. wins in 10 metrics, Nakoda Group of Industries Ltd. wins in 8 metrics, with 0 ties. Ajooni Biotech Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Ajooni Biotech Ltd. Nakoda Group of Industries Ltd. Better
P/E Ratio (TTM) 21.30 0.88 Nakoda Group of Industries Ltd.
Price-to-Book Ratio 0.77 2.01 Ajooni Biotech Ltd.
Debt-to-Equity Ratio 11.32 41.96 Ajooni Biotech Ltd.
PEG Ratio N/A 0.01 N/A
EV/EBITDA 11.17 150.60 Ajooni Biotech Ltd.
Profit Margin (TTM) 3.23% -3.63% Ajooni Biotech Ltd.
Operating Margin (TTM) 3.78% 7.33% Nakoda Group of Industries Ltd.
EBITDA Margin (TTM) 3.78% 7.33% Nakoda Group of Industries Ltd.
Return on Equity 5.51% -13.05% Ajooni Biotech Ltd.
Return on Assets (TTM) 3.58% -8.69% Ajooni Biotech Ltd.
Free Cash Flow (TTM) $-197.69M $-40.54M Nakoda Group of Industries Ltd.
1-Year Return -30.91% 24.14% Nakoda Group of Industries Ltd.
Price-to-Sales Ratio (TTM) 0.48 1.42 Ajooni Biotech Ltd.
Enterprise Value $803.44M $780.58M Ajooni Biotech Ltd.
EV/Revenue Ratio 0.53 1.69 Ajooni Biotech Ltd.
Gross Profit Margin (TTM) 22.46% 13.92% Ajooni Biotech Ltd.
Revenue per Share (TTM) $15 $30 Nakoda Group of Industries Ltd.
Earnings per Share (Diluted) $0.20 $42.24 Nakoda Group of Industries Ltd.
Beta (Stock Volatility) 0.44 -0.11 Nakoda Group of Industries Ltd.

Ajooni Biotech Ltd. vs Nakoda Group of Industries Ltd. Stock Performance Analysis

Loading Price Chart...

AJOONI
NGIL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ajooni Biotech Ltd.-1.58%-1.06%-10.53%-7.65%-15.77%-13.63%
Nakoda Group of Industries Ltd.-1.16%-9.42%-9.04%48.55%26.04%21.90%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ajooni Biotech Ltd.-30.91%-6.40%-51.96%-49.27%-49.27%-49.27%
Nakoda Group of Industries Ltd.24.14%-35.38%-41.25%-41.25%-41.25%-41.25%

Performance & Financial Health Analysis: Ajooni Biotech Ltd. vs Nakoda Group of Industries Ltd.

MetricAJOONINGIL
Market Information
Market Cap i₹733.76M₹658.63M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i369,15376,916
90 Day Avg. Volume i456,76342,592
Last Close₹3.74₹37.51
52 Week Range₹3.40 - ₹6.60₹22.01 - ₹43.89
% from 52W High-43.33%-14.54%
All-Time High₹85.85 (Feb 07, 2022)₹328.00 (Jan 03, 2022)
% from All-Time High-95.64%-88.56%
Growth Metrics
Quarterly Revenue Growth0.73%-0.25%
Quarterly Earnings Growth1.26%1,173.67%
Financial Health
Profit Margin (TTM) i0.03%-0.04%
Operating Margin (TTM) i0.04%0.07%
Return on Equity (TTM) i0.06%-0.13%
Debt to Equity (MRQ) i11.3241.96
Cash & Liquidity
Book Value per Share (MRQ)₹5.53₹18.37
Cash per Share (MRQ)₹0.01₹0.52
Operating Cash Flow (TTM) i₹-198,640,000₹-42,295,000
Levered Free Cash Flow (TTM) i₹33.72M₹-36,406,000
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: Ajooni Biotech Ltd. vs Nakoda Group of Industries Ltd.

MetricAJOONI (Apr 26, 2026)NGIL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i21.300.88
Forward P/E iN/AN/A
PEG Ratio iN/A0.01
Price to Sales (TTM) i0.481.42
Price to Book (MRQ) i0.772.01
Market Capitalization
Market Capitalization i₹733.76M₹658.63M
Enterprise Value i₹803.44M₹780.58M
Enterprise Value Metrics
Enterprise to Revenue i0.531.69
Enterprise to EBITDA i11.17150.60
Risk & Other Metrics
Beta i0.44-0.11
Book Value per Share (MRQ) i₹5.53₹18.37

Financial Statements Comparison: Ajooni Biotech Ltd. vs Nakoda Group of Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAJOONI (2025)NGIL (2025)
Revenue/Sales i1.15B453.61M
Cost of Goods Sold i970.28M414.80M
COGS % of Revenue i84.6%91.4%
Gross Profit i176.64M38.81M
Gross Margin i15.4%8.6%
Research & Development i0N/A
Operating Income (EBIT) i29.03M-31.64M
Operating Margin i2.5%-7.0%
EBITDA i48.51M-20.22M
EBITDA Margin i4.2%-4.5%
Pre-Tax Income i43.29M-48.62M
Pre-Tax Income % of Revenue i3.8%-10.7%
Income Tax i9.57M-12.22M
Income Tax % of Revenue i0.8%-2.7%
Net Income (Profit) i33.72M-36.41M
Profit Margin i2.9%-8.0%

Balance Sheet & Liquidity Metrics

MetricAJOONI (2025)NGIL (2025)
Cash & Equivalents i68.30M3.05M
Total Current Assets i620.04M282.50M
Total Current Assets % of Revenue i54.1%62.3%
Total Current Liabilities i48.21M128.63M
Total Current Liabilities % of Revenue i4.2%28.4%
Long-Term Debt i19.40M10.34M
Long-Term Debt % of Revenue i1.7%2.3%
Total Shareholders Equity i880.79M278.93M
Retained Earnings iN/A-17.15M
Retained Earnings % of Revenue i0.0%-3.8%
Property, Plant & Equipment i109.33M10.74M

Cash Flow Statement Comparison

MetricAJOONI (2025)NGIL (2025)
Operating Cash Flow i-198.64M-42.30M
Operating Cash Flow % of Revenue i-17.3%-9.3%
Capital Expenditures i9.56M-15.90M
Free Cash Flow i-197.69M-40.54M
FCF Margin i-17.2%-8.9%
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAJOONINGIL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i172.24M17.54M
Float Shares i124.23M6.55M
% Held by Insiders iN/A57.29%
% Held by Institutions iN/A0.00%
% Held by Public iN/A42.71%

Dividend Analysis & Yield Comparison: Ajooni Biotech Ltd. vs Nakoda Group of Industries Ltd.

MetricAJOONINGIL
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.13
3-Year Avg Dividend Yield iN/A0.23%
3-Year Total Dividends iN/A₹0.40
Ex-Dividend DateN/ASep 22, 2023